Oxford Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Oxford Immunotec Global PLC Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – OXFD
NEW YORK--(BUSINESS WIRE)--Jan 7, 2021--
Halper Sadeh LLP, a global investor rights law firm, is investigating whether Oxford Immunotec Global PLC (NASDAQ: OXFD) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Oxford to PerkinElmer, Inc. for $22.00 in cash per share.
On behalf of Oxford shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh encourages Oxford shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or email@example.com or firstname.lastname@example.org.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210107005897/en/
CONTACT: Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: LEGAL PROFESSIONAL SERVICES
SOURCE: Halper Sadeh LLP
Copyright Business Wire 2021.
PUB: 01/07/2021 04:58 PM/DISC: 01/07/2021 04:58 PM